# Prevalence and Characteristics of Fabry Disease (FD) in Patients With Stroke or Small Fiber Neuropathy

> **NCT03230149** · — · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 379 (actual)

## Conditions studied

- Fabry Disease

## Interventions

- **DIAGNOSTIC_TEST:** Measurements of the alpha-GAL enzyme activity

## Key facts

- **NCT ID:** NCT03230149
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-12
- **Primary completion:** 2021-12-24
- **Final completion:** 2021-12-24
- **Target enrollment:** 379 (ACTUAL)
- **Last updated:** 2022-09-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03230149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03230149, "Prevalence and Characteristics of Fabry Disease (FD) in Patients With Stroke or Small Fiber Neuropathy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03230149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*